FDA Inspection 1177888 - Andrew Rezvani, M.D. - August 19, 2022

Record Details

This FDA Inspection record concerns Andrew Rezvani, M.D., with an inspection on August 19, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Andrew Rezvani, M.D.
Inspection Date: August 19, 2022
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 5a9524a5-ffb1-40f6-b1f5-9b351b02a116

Violation Codes1

21 CFR 312.60

Full citation text and observation details available on the Dashboard.